265 related articles for article (PubMed ID: 17916379)
1. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
Brodde OE
Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379
[TBL] [Abstract][Full Text] [Related]
2. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
3. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
Leineweber K; Heusch G
Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
[TBL] [Abstract][Full Text] [Related]
4. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
6. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
7. Beta-2 adrenergic receptor genetic polymorphisms and asthma.
Hizawa N
J Clin Pharm Ther; 2009 Dec; 34(6):631-43. PubMed ID: 20175796
[TBL] [Abstract][Full Text] [Related]
8. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
[TBL] [Abstract][Full Text] [Related]
9. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms determine beta-adrenoceptor conformation: implications for cardiovascular disease and therapy.
Ahles A; Engelhardt S
Trends Pharmacol Sci; 2009 Apr; 30(4):188-93. PubMed ID: 19272658
[TBL] [Abstract][Full Text] [Related]
11. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
12. Genotype-dependent time course of lymphocyte beta 2-adrenergic receptor down-regulation.
Bruck H; Leineweber K; Beilfuss A; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2003 Sep; 74(3):255-63. PubMed ID: 12966369
[TBL] [Abstract][Full Text] [Related]
13. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
14. Association of haplotypes of beta2-adrenoceptor polymorphisms with lung function and airway responsiveness in a pediatric cohort.
Zhang G; Hayden CM; Khoo SK; Laing IA; Turner S; Landau L; Goldblatt J; Le Souëf PN
Pediatr Pulmonol; 2006 Dec; 41(12):1233-41. PubMed ID: 17068824
[TBL] [Abstract][Full Text] [Related]
15. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
[TBL] [Abstract][Full Text] [Related]
16. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
17. What role do adrenoreceptor polymorphisms play in modifying cardiovascular responses in obstructive sleep apnoea?
McArdle N
Clin Sci (Lond); 2006 Jan; 110(1):89-91. PubMed ID: 16287427
[TBL] [Abstract][Full Text] [Related]
18. Cardiac adrenoceptors: physiological and pathophysiological relevance.
Brodde OE; Bruck H; Leineweber K
J Pharmacol Sci; 2006; 100(5):323-37. PubMed ID: 16612046
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.
Mialet Perez J; Rathz DA; Petrashevskaya NN; Hahn HS; Wagoner LE; Schwartz A; Dorn GW; Liggett SB
Nat Med; 2003 Oct; 9(10):1300-5. PubMed ID: 14502278
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of beta1-adrenergic receptors in heart failure and hypertension.
Mialet-Perez J; Liggett SB
Arch Mal Coeur Vaiss; 2006 Jun; 99(6):616-20. PubMed ID: 16878723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
